bioRxivBioinformaticsPreprint
RareFoldGPCR: Agonist Design Beyond Natural Amino Acids
Abstract
Noncanonical amino acids (NCAAs) expand the chemical diversity of peptides beyond the twenty standard residues, offering new opportunities for designing binders with novel interaction modes and functional activity. G protein-coupled receptors (GPCRs) are central to cellular signalling and represent one of the largest classes of therapeutic targets, yet their functional modulation remains challenging. Here, we present RareFoldGPCR (RFG), a GPCR-specialised AI model for structure prediction and design that supports NCAAs. By applying transfer learning on high-resolution GPCR structures, RFG accurately models and rationally designs both linear and cyclic peptides that incorporate NCAAs and modulate GPCR activity. This is achieved without the model ever being trained on NCAA-based GPCR modulators. We showcase the capability of RFG by designing peptide agonists for the glucagon-like peptide-1 receptor (GLP1R) and validating their functional activity experimentally in cell-based assays. We investigate the precise capabilities of generating active agonists by expanding different regions of the native GLP-1 hormone, and further demonstrate the design of cyclic peptide agonists with entirely novel sequences and topologies, creating new agonist modes. We analyse how design metrics relate to pathway specificity, enabling precise modulation of pathway activity, such as activating the cAMP response without recruiting {beta}-arrestin to reduce receptor desensitisation. RFG shows how transfer learning on specific target classes enables generalisation to new chemistry and molecular topology, providing a broadly applicable strategy for designing functional ligands beyond the constraints of natural amino acid chemistry. RFG is freely available: https://github.com/patrickbryant1/RareFoldGPCR
- organism: human
- assay: protein structure
- research focus: drug response / drug discovery
- approach: deep learning
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Blind De Novo Design of Dual Cyclic Peptide Agonists Targeting GCGR and GLP1R
Qiuzhen Li, Elisée Wiita, … Patrick Bryant·bioRxiv·Jun 6, 2025
- Identification of key Y4R residues enables the discovery of selective non-peptide small-molecule agonists
Tim Pelczyk, Corinna Schüß, … Annette Gabriele Beck‐Sickinger·bioRxiv·May 1, 2026
- State-specific Peptide Design Targeting G Protein-coupled Receptors
Xue Wen Yang, Hongfei Wang, … Xiaomin Fang·Journal of Chemical Information and ModelingPeer-reviewed·Oct 11, 2025
- A complete RXFP1-relaxin interaction model unlocks the design of potent mini-protein modulators
Janik Clément, Tim Lkhagvajargal, … Rhys Grinter·bioRxiv·Jun 22, 2026
- A non-canonical mechanism of GPCR activation
Alexander S. Powers, Aasma A. Khan, … Ron O. Dror·Nature CommunicationsPeer-reviewed·Nov 16, 2024
- Structural dynamics underlying agonist activation of a GLP-1R-Gs precoupled complex
Jakub Sýs, Joseph D Ho, … Eamonn Reading·bioRxiv·Aug 4, 2026